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Diet has been hypothesized to play a role in the etiology of gastrointestinal cancer for a long time.
Initially, strong evidence of such effects was found in retrospective epidemiological studies.
Dietary habits, in particular those from the distant past, are difficult to measure, however. Results
from recent, prospective and larger studies of better quality did not always confirm these
associations. Consumption of fruits and vegetables appear to have a modest role in the
prevention of gastrointestinal cancers. In contrast, the roles of alcohol consumption and
overweight on risk of gastrointestinal cancer have become much clearer. Overweight and obesity
are important risk factors for adenocarcinoma (but not squamous carcinoma) of the esophagus,
gastric cardia carcinoma (but not noncardia carcinoma), and colorectal cancer, the latter in
particular among men. Alcohol consumption is a risk factor for squamous carcinoma (but not
adenocarcinoma) of the esophagus, gastric cancer and colorectal cancer. Selenium may be
inversely related to esophageal and gastric cancer.
Key words: esophageal neoplasms; stomach neoplasms; pancreatic neoplasms; colorectal
neoplasms; epidemiology; alcohol consumption; body weight; fruit; vegetables.
Information on the role of nutrition in the aetiology of cancer is usually derived from
carcinogenicity experiments on animals, in vitro mutagenicity experiments in bacterial
and mammalian cell test systems and epidemiological studies among humans. The main
disadvantage of in vitro and animal experiments is the problem of extrapolating results
to humans. Furthermore, it has been argued that, for example, contrasting theories ondoi:10.1016/j.bpg.2006.04.001
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590 P. A. van den Brandt and R. A. Goldbohmfat and colorectal cancer can be proved or disproved depending on the selected animal
model.1 As studies among humans provide the most realistic evidence on the cancer-
preventive potential of nutrition, this chapter will focus on epidemiological findings
about diet and cancer.
Among the most important epidemiological study types are the retrospective case-
control study and the prospective cohort study. In case-control studies on diet and
cancer, the investigator attempts to assess dietary habits of cancer cases in the past and
compare these with those of a (matched) control group without cancer. In prospective
cohort studies usual diet is assessed in a group of healthy subjects (the cohort), after
which these subjects are followed up for cancer incidence. Besides randomized
controlled trials, cohort studies provide the strongest evidence because of their
prospective nature. Nevertheless, due to chance and variability between studies
(caused by differences in design, population and methodology), confirmation of results
is very important. Therefore, epidemiologists follow a ‘weight of evidence’ approach, in
which information from all good-quality studies is combined. Much value is therefore
attached to meta-analyses and pooled analyses of studies.
We will now discuss overall findings from the various epidemiological studies
regarding the role of diet in the etiology of esophageal, gastric, pancreatic and
colorectal cancer. We will base our discussion as much as possible on published reviews
and meta-analyses, and evidence from prospective studies. Case-control studies will
only be used when there is no evidence from prospective studies. We also focus on
several common dietary risk factors for these tumors, such as fruit and vegetables,
alcohol and body weight, while allowing for important site-specific factors as well. We
will not discuss gene-nutrient interactions in this chapter, given space limitations and
current uncertainties surrounding this.ESOPHAGEAL CANCER
Esophageal cancer can be divided in esophageal squamous cell carcinoma (ESCC)—
mostly occurring in upper parts of the esophagus—which used to represent 90% of all
cases, and adenocarcinoma-mostly located in the lower third of the esophagus—which
used to represent 10% in the past. While the incidence of esophageal adenocarcinoma
(EAC) has increased rapidly over the past 3 decades in many western countries,2,3 in
the US, the incidence of EAC rose six fold from 1975–2001, more than any other major
cancer.4 At the moment, about 50% of new cases of esophageal cancer in the western
world are of the EAC type,5 while ESCC occurs at relatively high frequency in many
developing countries. Risk factors for both histological types differ substantially. Some
recent epidemiologic studies distinguish the histological types of esophageal cancer,6
but in many earlier studies this was not the case, and presumably these studies included
mostly ESCC cases. Both types have an extremely poor prognosis.
Alcohol
Besides smoking, alcohol drinking is an important risk factor—with a clear dose-
response relationship—for esophageal cancer, specifically for the squamous cell type
(ESCC). In western countries, about 90% of ESCC is caused by a combination of alcohol
and tobacco smoking. In a recent meta-analysis for esophageal cancer, including 27 case-
control studies and one cohort study, an increased risk of esophageal cancer was found
Table 1. Body mass index, alcohol and smoking and risk of ESCC, EAC, GCC, GNCC in a British cohort
study (data from Lindblad et al.13).
ESCC EAC GCC GNCC
Category OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI)
Body mass index (kg/m2)
!20 1.93 (0.90–4.11) 1.44 (0.67–3.10) 0.50 (0.12–2.10) 1.75 (1.00–3.08)
20–24 1.00 (ref) 1.00 (ref) 1.00 (ref) 1.00 (ref)
25–29 1.13 (0.71–1.80) 1.68 (1.18–2.40) 1.37 (0.89–2.10) 1.11 (0.80–1.54)
R30 0.28 (0.10–0.79) 1.93 (1.24–3.01) 1.46 (0.84–2.54) 0.87 (0.54–1.41)
p-trend pZ0.01 pZ0.005 pZ0.04 pZ0.18
Alcohol (units/day)a
0–2 1.00 (ref) 1.00 (ref) 1.00 (ref) 1.00 (ref)
3–15 1.01 (0.59–1.72) 1.06 (0.76–1.49) 1.08 (0.70–1.69) 0.99 (0.72–1.36)
16–34 2.44 (1.26–4.71) 0.69 (0.39–1.20) 1.22 (0.67–2.24) 0.91 (0.55–1.51)
Smoking status
Nonsmoker 1.00 (ref) 1.00 (ref) 1.00 (ref) 1.00 (ref)
Ex-smoker 0.61 (0.26–1.43) 1.07 (0.70–1.64) 1.40 (0.85–2.30) 1.10 (0.71–1.70)
Current smoker 1.64 (1.05–2.56) 1.45 (1.06–1.99) 1.38 (0.92–2.09) 1.70 (1.26–2.29)
a 1 unitZ7.9 g alcohol in United Kingdom.
Nutrition and gastrointestinal cancer 591beginning at two alcoholic drinks per day.7 A Japanese cohort study, not included in the
meta-analysis, found a relative risk of over two for death due to esophageal cancer for
people drinking alcoholic beverages four or more times per week.8 This increased risk
is not limited to particular types of alcoholic beverages (e.g. calvados), but occurs with
any type of alcoholic beverages, suggesting that this increased risk is attributable to
alcohol itself (ethanol). Nevertheless, several studies have observed stronger risk
increases among consumers of stronger drinks, and therefore an additional risk
increase due to specific contaminants cannot be ruled out. Alcohol drinking and
tobacco smoking act synergistically in increasing the risk of ESCC. The risk of EAC is
not or only weakly related to alcohol drinking9–13 (Table 1).Body weight
In contrast to alcohol drinking, being overweight or obese is associated with an
increased risk of EAC and not with ESCC risk. Almost all studies, among them three
cohort studies, report a positive association between overweight and EAC risk.14 In
most case-control studies, increased risks were observed with higher body mass index
(BMI, body weight divided by height squared (kg/m2)), notably with obesity.11,15 In the
US Cancer Prevention Study16, BMI was positively associated with esophageal cancer
mortality; no distinction between histological subtypes was made. In a Norwegian
cohort study overweight and obesity were associated with increased risks of EAC in
both men and women (RRs ranging from 2.1 to 2.6 for BMI of 30Ckg/m2). Opposite
associations were found with risk of ESCC in men and women.17 Comparable results
were reported from England13 (Table 1).
An increased incidence of gastric reflux due to abdominal pressure has been
proposed as the underlying (intermediate) cause of the elevated risk of adenocarcinoma
in persons with high BMI.18 However, the association between BMI and risk of EAC was
also observed for subjects without gastro-esophageal reflux symptoms11,13; this
592 P. A. van den Brandt and R. A. Goldbohmsuggests that other mechanisms than reflux may (also) be behind the elevated risk for
those with high BMI. Still few prospective data are available on this issue.
Fruits and vegetables
More than 30 case-control studies, often hospital-based, have been published on fruit
intake and esophageal cancer. A recent IARC report19 concluded from the case-control
studies that the mean OR was 0.54 (95% CI 0.48–0.61), range 0.14–1.50, comparing
subjects in high intake categories with subjects in low intake categories. Only three
cohort studies have been reported, two from China and one from Japan. A borderline
significant inverse association was found with total fruit intake in Japan20. No
associations were found in the Chinese studies, however.21,22 Regarding vegetables,
IARC arrived for the case-control studies at a mean ORZ0.64 (95% CI 0.57–0.72),
range 0.10–0.97.19 Four cohort studies were conducted in China or Japan. The Japanese
studies found no association,20,23 whereas the Chinese studies reported (borderline)
significant inverse associations with vegetables.21,22 Few case-control and no cohort
studies have been reported on EAC specifically; the IARC report did not indicate clear
differences in associations between EAC and ESCC, however.
Vitamins and minerals
High intake of antioxidants, such as vitamins C and E, selenium and beta-carotene, may
have a protective effect on the risk of certain upper GI malignancies. Case-control
studies analysing for beta-carotene, vitamins B2, C and E intakes have tended to find
inverse associations between intakes of these nutrients and risk of esophageal cancer. A
large randomized intervention trial of vitamin and mineral supplementation was
conducted in Linxian, China, known for its high rates of esophageal and gastric cancer
and a low intake of several micronutrients. Overall mortality decreased in those
receiving supplementation with beta-carotene, vitamin E, and selenium, mainly due to
lower stomach cancer rates (relative risk, 0.79; 95% CI, 0.64–0.99).24 In a follow-up
study from the Linxian trial, subjects with esophageal dysplasia who were receiving
multivitamin and multimineral supplementation had regression of the dysplasia.25 The
effects of separate vitamins and minerals could not be teased out, however. In a
randomized controlled trial from the US, a nonsignificant reduction in mortality from
esophageal cancer (RRZ0.33; 95% CI, 0.03–1.84), was observed in subjects receiving
selenium.26 Also from the Linxian trial, pretrial serum selenium levels were inversely
associated with the incidence of esophageal and gastric cardia tumors.27,28 In a
prospective cohort study conducted in Finland, a low selenium region prior to
fertilization of the soil with selenium, a lower risk of esophageal and stomach cancer in
individuals with relatively high baseline serum selenium levels was observed.29GASTRIC CANCER
It is important to discern between adenocarcinoma of the proximal stomach (cardia,
GCC) and adenocarcinoma arising in other parts of the stomach (body, GNCC). The
prognosis of proximal cancers may be even worse than those of distal cancers.30 While
the incidence of gastric noncardia cancer has sharply declined in the past decades,
the incidence of gastric cardia cancer (GCC) has increased quite rapidly over the past
Nutrition and gastrointestinal cancer 593three decades in many western countries, together with EAC.2 The commonly
occurring infection with H. Pylori, which also causes gastric ulcers, increases the risk of
gastric cancer two-to-threefold.31 Earlier, it was estimated that 35–60% of gastric
cancers can be attributed to H. Pylori infection.32–34 However, in a recent combined
analysis of 12 prospective cohort studies, it was concluded that H. Pylori infection does
not increase the risk of GCC, but the risk of GNCC is 5.9 times elevated for those
infected with H. Pylori.35 Thus, H. Pylori infection is only an established risk factor for
GNCC and is estimated to be responsible for about 10% of the GNCC risk in the
American population, according to a very large case-control study.36 GCC may have
different aetiological factors than GNCC.
Alcohol
In a recent meta-analysis, based on 14 case-control studies and two cohort studies, a
positive association was found between drinking alcoholic beverages and gastric cancer
risk.7 Regarding GCC specifically, the results are mixed.
Body weight
Although overweight and obesity have traditionally not been linked to gastric cancer risk,
recent prospective evidence suggests that the risk of GCC is positively associated with
BMI13, Table 1. In a British cohort study, BMI was associated with risk of GCC, in a dose-
dependentmanner, but notwith riskofGNCC.The associationwith obesity (BMIO30 kg/
m2) was stronger for EAC (RRZ1.93) than for GCC (RRZ1.46); both associations
seemed independent of gastro-esophageal reflux and were found in men and women.13
Fruits and vegetables
More than 37 case-control studies have been published on gastric cancer and fruit
intake. A recent IARC report19 concluded from the case-control studies that the mean
OR was 0.63 (95% CI, 0.58–0.69), range 0.31–1.39, comparing subjects from high fruit
intake categories with subjects from low intake categories. A total of 11 cohort studies
have been reported; the mean RR of these studies was 0.85 (95% CI, 0.77–0.95), range
0.55–1.92, comparing high to low intakes. Regarding vegetables, IARC arrived for the
20 available case-control studies at a mean OR of 0.66 (95% CI, 0.61–0.71), range 0.30–
1.70. The five cohort studies on vegetables and stomach cancer showed a mean RR of
0.94 (95% CI, 0.84–1.06), range 0.70–1.25, comparing high to low intakes. For both
fruits and vegetables, the IARC analyses showed significant heterogeneity between the
ORs from case-control studies, but not from cohort studies.19 Two case-control and
two cohort studies have reported on GCC specifically; no differences in the
associations between GCC and GNCC. Prospective studies have shown weaker
inverse associations than case-control studies, and evidence is available that the
apparent inverse association seen in case-control studies might be due to recall bias
because of lower intake following prediagnostic symptoms.37
Vitamins and minerals
Possible protective micronutrients from fruits and vegetables include vitamin C, vitamin
E, beta-carotene and other carotenoids and selenium. Regarding vitamin C, case-
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low intake. There were no inverse associations with other vitamins/carotenoids. The
few other cohort studies on this issue show mixed results. Two randomized nutrition
intervention trials on the effects of vitamin/mineral supplementation on the occurrence
of gastric carcinoma showed conflicting results. A trial in Linxian, China, showed that
supplements containing b-carotene, vitamin E, and selenium reduced the incidence of
gastric carcinoma with 16% and the mortality with 21% after 5.25-year intervention,24
whereas, in the ATBC trial in Finland, more cases of gastric carcinoma were diagnosed
among those who received b-carotene or a-tocopherol compared with those who did
not.38 In the Linxian Trial, it is not clear whether a specific component or combination
of components of the supplement were responsible for the reduced risk. For gastric
cancer, suggestive, but inconsistent, evidence was found for an inverse relationship with
toenail selenium (RRZ0.6 for highest vs. lowest selenium category) in the NLCS.39
A chemoprevention trial of gastric dysplasia in which 2 g vitamin C or 30 mg
b-carotene supplements (as antioxidants) and anti-H. Pylori therapy were tested singly
or in combination for 6 years in Colombia demonstrated that all three treatments were
successful regarding lesion regression rates, with no additional benefit from combining
treatments.40 However, H. Pylori treatment seemed to be only effective when given
singly; some indication of adverse effects was seen when it was administered together
with b-carotene or vitamin C. The effects of the treatments on lesion progression were
less clear.Salt
Most case-control studies have shown a positive association between intake of salt or
salted food and gastric cancer. The few cohort studies that reported results on salt or
salted food and stomach cancer risk found no clear associations.41 In one recent
Japanese cohort study no significant association with intake of pickled foods and
traditional soups and gastric cancer risk was found42 while in another cohort study a
significant positive association between salt intake and risk of gastric cancer was seen in
men, but not in women.43 In the NLCS, the results suggested that intake of dietary salt
and several types of cured meat were weakly positively associated with gastric cancer
risk.44 Thus, the link between salt and gastric cancer is not consistently observed. It is
possible that the increased risks could be attributed to other compounds of the foods
(possible carcinogens) developed during the preservation process, and not to salt
content of the foods.45 As in the NLCS, use of table salt was not associated with
stomach cancer risk in the only other cohort study that reported on this association.46
Also, gastric cancer rates in the USA are low, even though salt intake is not.Nitrate, nitrite, nitrosamines
Nitrate can be converted into nitrite and in a nitrosation reaction to N-nitroso
compounds (e.g. nitrosamines); these are carcinogenic in animal experiments.
However, the extrapolation of these results—often obtained with high intakes—to
humans and human intake levels is uncertain. In case-control and cohort studies,
little evidence has been found regarding nitrate or nitrite intake from food or drinking
water and gastric cancer risk (e.g.47,48). It seems fair to conclude that nitrate does not
increase gastric cancer risk, and it is not advisable to reduce vegetable intake because of
nitrate, given the possible beneficial effects of high vegetable intake on gastric cancer
Nutrition and gastrointestinal cancer 595risk. There are very few epidemiological studies on dietary nitrosamines and stomach
cancer. Nitrosamines occurred in the past in smoked and salted fish, cured meats and
beer, and appeared to increase the risk of gastric cancer in a French study,47 but not in a
Finnish study.49 Due to other methods of food preservation (e.g. refrigeration, addition
of vitamin C and E to cured meats, which block the nitrosation reaction) levels of
nitrosamines in foods have substantially decreased.PANCREATIC CANCER
Pancreatic cancer is a relatively rare but highly fatal cancer, with 5-year survival rates of
less than 5%. Regarding its etiology, still very few risk factors are known, also in the area
of nutrition.
Alcohol
Ten prospective studies have evaluated the association between alcohol and pancreatic
cancer risk. While four studies found an increased risk for alcohol drinkers, findings
were not always significant and one study made no adjustment for smoking, which is
one of the few established risk factors. The other six studies reported no significant
associations with alcohol intake. Because of possible residual confounding by smoking,
and given the overall results, it seems that alcohol is not an important risk factor for
pancreatic cancer.
Body weight
Overweight and obesity possibly increase the risk of pancreatic cancer. In recent years,
various cohort studies have shown elevated risks among overweight and obese
subjects, but this is not consistently observed. A meta-analysis of 14 case-control and
cohort studies on obesity and pancreatic cancer yielded an OR of 1.02 (95% CI, 1.01–
1.03) per unit increase in BMI, or equivalently, an OR of 1.19 (95% CI, 1.10–1.29) for a
BMI of 30 versus 22 kg/m2.50The association was seen in men and women, and in case-
control and cohort studies, but the analysis was heavily influenced by the results of the
large ACS Cancer Prevention Study.16 It suggests that pancreatic cancer risk is weakly
associated with obesity, but confounding cannot be excluded.
Diabetes mellitus
Type II diabetes is associated with increased pancreatic cancer risk in many studies.
There was doubt about the causal nature of this relationship because pancreatic tumors
may also lead to diabetes. In a meta-analysis of 20 studies with data on the duration of
diabetes prior to pancreatic cancer, subjects who had diabetes for 5 or more years had
a twofold increased risk (95% CI, 1.2–3.2) of pancreatic cancer compared to individuals
without diabetes, or diabetes for less than 5 years.51 Using additional data from other
studies, it has been concluded that diabetes, that develops 10 or more years prior to
cancer diagnosis, is causally related to pancreatic cancer.
The associations between body weight and diabetes suggest that insulin resistance
may play a role in pancreatic carcinogenesis.52 Following this reasoning, some evidence
has been found that impaired glucose metabolism may play a role, and that a diet high in
596 P. A. van den Brandt and R. A. Goldbohmglycemic load may increase pancreatic cancer risk in women who already have an
underlying degree of insulin resistance.52Fruits and vegetables
Regarding fruit consumption, a recent IARC review19 concluded that, when comparing
high versus low intake, the mean OR for 6 case-control studies was 0.72 (95% CI, 0.63–
0.83), range 0.07–0.92. Nonsignificant inverse associations were also found in three
cohort studies. For vegetables, the mean OR in 5 case-control studies was 0.80
(95% CI, 0.69–0.93), range 0.32–1.03. In two cohort studies, nonsignificant inverse
associations were found. Case-control studies on pancreatic cancer are difficult to
interpret because of selection bias due to low response rates among cases and controls,
and interviewing of next-of-kins for deceased cases. This might explain why inverse
associations from case-control studies are not replicated in cohort studies.Other dietary factors
IARC has concluded in 1991 that there is little evidence for a positive association
between coffee and pancreatic cancer.53 The majority of the 13 cohort studies
published since then are consistent with this conclusion. Other possible dietary risk
factors include (processed) meat and fat consumption,54 carbohydrate and sugar intake,
and sugar-sweeted soft drinks.55 Too few cohort studies are available to draw
conclusions, however.COLORECTAL CANCER
Colorectal cancer is usually divided in colon and rectal cancer. The incidence of
colon cancer has been increasing in developed countries including Japan, whereas
rectal cancer has decreased in Europe56 and remained constant in Japan.57 The differing
time trends provide evidence that the etiology of both cancer sites is not the same.
Besides colorectal cancer, colorectal adenoma are sometimes studied as a early
endpoint or predictor of colorectal cancer, as adenoma are likely to be in the pathway
of development of malignant tumors through a series of genetic alterations.58Alcohol
Meta-analyses have shown that alcohol consumption is a risk factor for colon and rectal
cancer, in men and women, but quantification of the increase in risk was difficult.59,60 A
recent pooled data analysis, including half a million men and women from eight cohort
studies in five countries, found that the risk was increased starting from an alcohol
consumption of 30 g (w3 drinks) per day.61 Compared to nondrinkers, risk increased
with 16% for those drinking 30–45 g alcohol and with 42% for those drinking more than
45 g per day. The type of alcoholic beverage did not seem important, alcohol itself
appeared to be the most important factor. All eight studies included in the pooled
analysis were consistent for men and women and for colon and rectal cancer.
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Cohort studies have demonstrated that overweight and obesity increase the risk of
colon cancer, more clearly in men than women.62 Recent, very large cohort studies in
many parts of the world have confirmed that the risk increases with, for example, 4%
for each unit increase in BMI in Norwegian men63 and 2.5-fold for obese Austrian men
with a BMI OZ35.64 Most of these studies observed no or an only weakly increased
risk of colon cancer for overweight and obese women. The association between BMI
and rectal cancer is much less pronounced. One study found that waist circumference is
a better predictor of colon cancer risk than BMI and showed that risk increases linearly
with increasing waist size.65 This association was more pronounced in sedentary
people.
Physical activity was one of the first factors identified that seemed to consistently
protect against colon cancer in men and women. The evidence based on case-control
studies is convincing. Cohort studies, however, tended to find less consistent results.
This may be due to a lower quality of the physical activity assessment in the cohort
studies. Risk of rectal cancer does not appear to be influenced by physical activity.
It is noteworthy that colorectal cancer and type 2 diabetes seem to share many risk
factors. Plasma c-peptide (an indicator of insulin production) appeared to be a strong
predictor of colorectal cancer in the Physicians’ Health Study, independently of BMI.66Fruits and vegetables
Until recently, it was generally assumed—based on case-control studies and a few small
cohort studies—that consumption of a lot of fruits and vegetables would protect
against colorectal cancer. Several large cohort studies published since did not
consistently confirm this association, however;67–69 only a few studies, conducted in
Sweden,70 the Netherlands71 and the United States,72 found that high consumption of
fruits or fruits and vegetables together showed a decreased risk of colorectal cancer.
For the cohort studies, IARC estimated a summary RR of 1.00 (95% CI, 0.96–1.05) for
fruit and 0.97 (0.87–1.08) for vegetable intake.19 Altogether, consumption of fruits and
vegetables may have a small role, if any, in the prevention of colorectal cancer.Dietary fibre
Dietary fibre is a summary term for several types of complex (mainly) carbohydrates
that are not digested in the gastrointestinal tract. In a mixed diet, 70–80% of the fibre is
fermented and degraded by the intestinal flora. For practical purposes, fibre is divided
according to source: vegetable, fruit and cereal fibre or according to physical
properties, i.e. soluble and insoluble. Vegetable and fruit fibre is mainly soluble, whereas
cereal fibre is mainly insoluble.
One of the oldest hypotheses in the aetiology of colorectal cancer is the fibre
hypothesis. It is based on observations that colorectal cancer is uncommon in
developing countries with a high fibre intake and its biological plausibility. Bulking and
intestinal transit are both increased with a high fibre diet and could lead to a decreased
exposure of the mucosa to carcinogens present in the lumen.
Case-control studies generally observed a decreasing risk with increasing fibre
intake.73,74 This was seen for colon and rectal cancer and for men and women. A
number of recent, large cohort studies did not observe a protective effect of dietary
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period into account.75 The EPIC study, a European prospective multi-centre cohort
study, based on 1000 cases, showed, however, that dietary fibre intake decreased the
risk of colorectal cancer with about 25% in the highest intake quintile (i.e.O34 g per
day) compared with the lowest quintile (!13 g per day). The association was seen in
both sexes, was stronger for colon than for rectal cancer and strongest for cereal and
fruit fibre.76 Further analysis including 1700 cases confirmed these results and showed
that the association was most pronounced for tumors in the distal colon.77 Most other
available cohort studies contributed to a pooled data analysis including 8000 cases of
colorectal cancer.78 This analysis found no association between dietary fibre intake and
colorectal, colon or rectal cancer. It is not known why these results differ across the
two studies, although some explanations have been put forward.79 Intake of the same
amount of fibre may represent a different fibre composition across studies.
Measurement error may play a role, but some of the same studies that did not
observe an association with colorectal cancer, did observe one with heart disease.80
The effect of fibre supplementation on adenoma recurrence was also studied in two
chemoprevention trials among subjects who had at least one adenoma removed, each
lasting 3 years. One study treated the treatment group with a cereal fibre supplement81
and the other study prescribed a diet high in fibre, vegetables and fruits and low in fat.82
Neither study observed an effect of fibre intake on adenoma recurrence.Meat and fat
In the nineties, two American cohort studies observed increased risks of colon cancer
with consumption of meat, in particular red meat (beef, pork and lamb).83,84 Since, then
much research has been done to confirm these results. Several reviews and meta-
analyses have summarised their findings.85–87 A few studies confirmed the positive
association, but many other studies did not. The comparison was complicated due to
differences in meat variables between the studies. For example, in some studies red
meat comprised processed meat, in others it did not.
A positive association between consumption of processed meat (i.e. sausages and
other cured meats) and colon cancer appeared to be much more consistent; a meta-
analysis calculated that an increase in consumption of 25 g processed meat per day
increased risk with 50%.86 It is speculated that the consistently increased risk may be
due to the former presence of nitrosamines in cured meat.
Recent large cohort studies, including a reanalysis of the two mentioned before,
show a weak association between fresh (red) meat consumption and colorectal
cancer.88–91 Again, the comparison is complicated as in some of these studies (red)
meat consumption included processed meat. With exception of one of these studies,90
all observed an increased risk of colorectal cancer with consumption of processed
meat. Studies comparing vegetarians with nonvegetarians demonstrated no difference
in colorectal cancer risk between the two groups.92–94
It is also hypothesised that the differences in results are attributable to preparation
methods of meat: meat fried at high temperature and with a dark surface contains more
mutagenic heterocyclic amines (HCAs) than meat prepared differently. Again, this
association with HCAs was confirmed in some studies, but not in others. Barbecuing and
grilling introduce polycyclic aromatic hydrocarbons (PAHs) into the meat; this may also
contribute to the increase in risk95, butmore researchhas tobedone. Itmay be that people
with a rapid acetylator (NAT2) genotype are more susceptible to these carcinogens in
Nutrition and gastrointestinal cancer 599meat.96 Last but not least, it may be that heme, present in (red) meat in varying amounts,
increases the risk for colorectal cancer, but the evidence is not yet conclusive.97
Intake of fat has not found to increase risk of colorectal cancer.
Dairy and calcium
Consumption of dairy products, in particular milk, yoghurt, and buttermilk, is
associated with a small decrease in risk of colorectal cancer, as was shown by a pooled
analysis of 10 cohort studies including 5000 cases. Consumption of half a litre of milk
contributed to 11% decrease in risk.98 A similar association was observed for calcium in
this study. It has been proposed that calcium may decrease risk due to its capacity to
saponify fatty and cholic acids in the lumen. The association was confirmed in an
intervention trial among subjects in whom a colorectal adenoma had been removed.
After a 4-year treatment with 1200 mg calcium, adenoma recurrence was 19% lower
than in the placebo group.99Research agenda
† study the role of nutrition in subsites and histological subgroups of GI cancers
† further study into the role of (red and processed) meat and fibre in CRC is
needed
† prospective studies on upper GI cancers are highly needed
† development of valid, applicable biomarkers of early disease is highly needed, to
enable further RCTs
† detailed studies on interaction between genetic susceptibility and dietary
factors in GI cancers
† investigate the role of diet in subgroups of cancer defined by somatic mutations
in tumor suppressor or oncogenes
Practice points
† ample consumption of fruits and vegetables may modestly decrease risk of
most gastrointestinal cancers
† alcohol intake is a risk factor for colorectal cancer and ESCC, but is not or only
weakly associated with EAC, gastric cancer and pancreatic cancer
† risk factors for ESCC (smoking and alcohol) differ strongly from those for EAC
(high bodyweight). The dramatic increase in incidence of EAC may largely be
due to increase of obesity
† overweight and obesity are also risk factors for colorectal cancer (particularly
in men), gastric cardia cancer and possibly pancreatic cancer
† there is suggestive evidence that low selenium intake increases risk of
esophageal and gastric cancer
† the role of dietary fibre and (red) meat in colorectal cancer is still controversial
† all things considered, a diet including fruits, vegetables and other plant foods,
modest amounts of meat and alcohol and aiming at avoiding overweight, has
the best chance of a modest reduction of the risk of gastrointestinal cancer
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